Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can’t be surgically removed.
The platform allows for greater precision and thoroughness in cancer treatment.
Here’s how it works:
Nanoparticles tightly loaded with a dye compound are administered systemically – injected intravenously or into the peritoneum, the abdominal cavity. When they reach the tumor site, the tumor’s intracellular environment effectively flips the switch on the compound’s fluorescence.
That enables detection by a near infrared (NIR) imaging system that helps surgeons know in real time what needs to be removed.
Any glowing areas that can’t be cut out are given phototherapy – irradiated with a near infrared laser, which causes the nanoparticles to heat up and kill the residual cancer cells.
The findings by researchers in the OSU/OHSU College of Pharmacy and OSU College of Veterinary Medicine were published this month in Theranostics.
The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially – until the tumor activates the fluorescence by loosening the packing – it doesn’t cause any non-cancerous tissue to glow.
Corresponding authors Olena Taratula and Oleh Taratula of the Department of Pharmaceutical Sciences and their collaborators evaluated the platform in vitro and in two different mouse models, including one that mimicked ovarian intraperitoneal metastasis.
The research team operated on the mice using real-time imaging, which showed that the new nanoparticles are compatible with a standard, FDA-approved imaging system. The efficacy of the phototherapy was also demonstrated in vivo.
“The nanoplatform system is quite simple but quite effective,” Olena Taratula said.
Subsequent laboratory testing of the platform will include rats, she said, followed by testing on dogs that are already scheduled for cancer surgeries at the College of Veterinary Medicine.
“They’re going to do surgery on those dogs anyway, and they can use our nanomedicine platform as an additional tool to see if they can identify the cancer cells,” Taratula said.
The Latest on: Flourescent nanomedicine
- Nanomedicine Market : Global Market Opportunities, Size, Share, Emerging Trends, Technological Innovation And Forecasts To 2023on November 19, 2019 at 10:10 pm
Nanomedicines are used as fluorescent markers for diagnostic and screening purposes. Moreover, nanomedicines are introducing new therapeutic opportunities for a large number of agents that cannot be ...
- FRET in a Polymeric Nanocarrier: IR-780 and IR-780-PDMSon October 31, 2019 at 12:42 pm
Nanomedicine Research Lab CLINAM, University Hospital Basel ... We introduce a method to monitor the integrity of micellar nanocarriers using a novel fluorescent dye, IR-780-PDMS and Förster resonance ...
- Quantum dots that light up TVs could be used for brain researchon October 16, 2019 at 3:07 am
Because of their unique optical properties – they can produce thousands of bright, sharp fluorescent colors – scientists ... Our results offer a warning: Nanomedicine research in the brain makes no ...
- Quantum dots that light up TVs could be used for brain researchon October 15, 2019 at 5:32 am
Because of their unique optical properties – they can produce thousands of bright, sharp fluorescent colors – scientists ... because scientists are concerned about their use in human beings ...
- Glutathione-mediated biotransformation in the liver modulates nanoparticle transporton July 15, 2019 at 8:19 am
By designing a thiol-activatable fluorescent gold nanoprobe that can bind to serum ... With this biotransformation, liver detoxification, a long-standing barrier in nanomedicine translation, can be ...
- MSK-Cornell Center for Translation of Cancer Nanomedicineon March 6, 2018 at 8:33 am
The goal of the MSK-Cornell Center for Translation of Cancer Nanomedicine (MC 2 TCN) is to advance, translate, and disseminate a suite of ultrasmall (
- Fluorescent Nanomedicine Guiding Tumor Removalon February 1, 2018 at 4:00 pm
A nanomedicine platform has been developed for use with the treatment of cancer that will help doctors to know which tissue to cut away for removal as well as kill any malignant cells which are not ...
- Fluorescent nanomedicine can guide tumor removal, kill remaining cancer cellson December 20, 2017 at 4:00 pm
The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially - until the ...
- Fluorescent nanomedicine can guide tumor removal, kill remaining cancer cellson December 19, 2017 at 4:00 pm
The nanomedicine platform consists of silicon naphthalocyanine (SiNc) densely packed in biodegradable PEG-PCL nanoparticles. Because the SiNc is engineered to be non-fluorescent initially -- until the ...
via Google News and Bing News